KSQ Therapeutics, Inc.

KSQ Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer and autoimmune diseases. Their unique approach centers on the CRISPRomics® platform, a genome-wide CRISPR/Cas9 functional genomic screening technology that identifies and validates top therapeutic targets across a broad range of cancer models and immune cell types. This platform has generated a pipeline of promising drug candidates targeting both tumors and the immune system, spanning multiple modalities, including targeted therapies, adoptive cell therapies, and immunotherapies.

KSQ is advancing several key programs, including their lead engineered tumor-infiltrating lymphocyte (eTIL®) programs, KSQ-001EX and KSQ-004EX, which have the potential to revolutionize the treatment of solid tumors. They have also developed KSQ-4279, a first-in-class small molecule inhibitor of USP1, currently in Phase 1 clinical trials for the treatment of various solid tumors. KSQ's commitment to scientific innovation and a strong pipeline of drug candidates positions them as a leading player in the fight against cancer and autoimmune diseases.

KSQ Therapeutics is a clinical-stage biotechnology company focused on discovering and developing novel therapies with curative potential, particularly in the area of cancer. Their mission is to drive cures in hard-to-treat diseases by leveraging their proprietary CRISPRomics® platform to optimize the therapeutic potential of cells and turn genomic insights into transformative medicines.

KSQ Therapeutics promotes a culture that prioritizes collaboration, innovation, and a supportive environment. Their core values, represented by the acronym CARE, emphasize collaboration, authenticity, respect, and excellence. They believe that everyone, from individual contributors to teams, can contribute to the next groundbreaking idea or breakthrough, fostering an open and inclusive atmosphere where employees feel comfortable sharing ideas and working together to achieve their ambition to cure.

KSQ Therapeutics believes in creating a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered. They are committed to fostering an environment that celebrates differences and provides opportunities for growth and development for all. This commitment is reflected in their core values, which emphasize collaboration, innovation, inclusivity, and support. KSQ strives to build a company culture where every voice is heard and valued, ensuring a positive and productive work environment for all.